User profiles for Alisa M. Higgins
 | Alisa HigginsMonash University Verified email at monash.edu Cited by 13456 |
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, M Fitzgerald, H Goossens, R Haniffa, AM Higgins… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
[PDF][PDF] Goal-directed resuscitation for patients with early septic shock
Background Early goal-directed therapy (EGDT) has been endorsed in the guidelines of the
Surviving Sepsis Campaign as a key strategy to decrease mortality among patients …
Surviving Sepsis Campaign as a key strategy to decrease mortality among patients …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
…, M Buxton, A Buzgau, AC Cheng, M de Jong, M Detry… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults
…, LR Caruana, D Elliott, M Green, K Haines, AM Higgins… - Critical care, 2014 - Springer
Introduction The aim of this study was to develop consensus recommendations on safety
parameters for mobilizing adult, mechanically ventilated, intensive care unit (ICU) patients. …
parameters for mobilizing adult, mechanically ventilated, intensive care unit (ICU) patients. …
The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design
…, A Gordon, C Green, AM Higgins… - Annals of the …, 2020 - atsjournals.org
There is broad interest in improved methods to generate robust evidence regarding best
practice, especially in settings where patient conditions are heterogenous and require multiple …
practice, especially in settings where patient conditions are heterogenous and require multiple …
Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial
Importance After severe traumatic brain injury, induction of prophylactic hypothermia has
been suggested to be neuroprotective and improve long-term neurologic outcomes. Objective …
been suggested to be neuroprotective and improve long-term neurologic outcomes. Objective …
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
Background There are few reports of new functional impairment following critical illness
from COVID-19. We aimed to describe the incidence of death or new disability, functional …
from COVID-19. We aimed to describe the incidence of death or new disability, functional …
A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory …
…, DV Tuxen, AR Davies, MJ Bailey, AM Higgins… - Critical care, 2011 - Springer
Introduction Tidal volume and plateau pressure minimisation are the standard components
of a protective lung ventilation strategy for patients with acute respiratory distress syndrome (…
of a protective lung ventilation strategy for patients with acute respiratory distress syndrome (…
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …
investigation in numerous randomized clinical trials, but results are publicly available only for a …
